March 1, 2023

Corium Pharma Solutions Names Suzanne Hinchliffe as Chief People Officer

January 26, 2023

Innocoll Holdings Ltd. Appoints Kimball Hall as Chief Executive Officer

January 17, 2023

Corium Pharma Solutions Appoints Mark Sirgo as Chief Executive Officer

October 20, 2022

Corium and Gurnet Point Capital Announce Manufacturing Business Acquisition and a $100 Million Neuroscience Therapeutics Investment by Webster Equity Partners, Establishing Two Independent Growth Companies

August 15, 2022

Gurnet Point Capital and Patient Square Capital Complete Their Acquisition of Radius Health, Inc.

April 1, 2021

Crossover Health Raises $168 Million to Grow Primary-Health Services

April 1, 2021

Tremeau Pharmaceuticals Will Advance Non-Opioid Pain Program with Investment from Gurnet Point Capital

August 31, 2020

FDA Approves XARACOLL® (bupivacaine HCl) Implant, a Non-opioid, Drug-device Treatment Option for Acute Postsurgical Pain Relief for up to 24 Hours Following Open Inguinal Hernia Repair in Adults